John P. Butler, CEO and President of Akebia Therapeutics, Inc. (NASDAQ: AKBA), filed a Form 4 on August 10, 2026, reporting the exercise of 350,000 stock options on August 6, 2026.
Joseph R. Holmes, VP and Chief Accounting Officer of Thermo Fisher Scientific Inc., filed a Form 4 on August 10, 2026, disclosing the exercise of 420 stock options and the same-day sale of 420 shares of common stock on August 7, 2026.
Director Jane Grebenc of First Commonwealth Financial Corp /PA/ filed a Form 4 with the SEC on August 10, 2026, reporting the sale of common stock shares on August 6, 2026, on NYSE under the ticker FCF.
Lee E. Lyon II, EVP and Chief Audit Executive of First Commonwealth Financial Corp /PA/ (FCF), filed a Form 4 on August 10, 2026, reporting six open-market sales of common stock and the receipt of a service-based restricted stock unit award on the same …
Steven I. Sarowitz, a director and 10% owner of Paylocity Holding Corp (NASDAQ: PCTY), filed a Form 4 on August 10, 2026, disclosing the sale of 11,136 shares of common stock on August 6, 2026, under a pre-established Rule 10b5-1 trading plan.
Director Elisabetta Magistretti filed a Form 4 with the SEC on August 10, 2026, disclosing the sale of ordinary shares in Stevanato Group S.p.A. (NYSE: STVN) on August 7, 2026, to cover tax obligations associated with a share grant.
Marco Dal Lago, Chief Financial Officer of Stevanato Group S.p.A. (STVN), filed a Form 4 on August 10, 2026, disclosing the sale of ordinary shares on August 7, 2026, to cover tax obligations associated with a share grant.
Director Luciano Santel filed a Form 4 with the SEC on August 10, 2026, disclosing the sale of ordinary shares of Stevanato Group S.p.A. (NYSE: STVN) on August 7, 2026, to cover tax obligations associated with a share grant.
Christoph Glingener, Chief Technology Officer of ADTRAN Holdings, Inc., filed a Form 4 with the SEC on August 10, 2026, disclosing the acquisition of 27,924 shares of common stock at no cost.
Director Steven J. Hamerslag filed a Form 4 with the SEC on August 10, 2026, reporting the acquisition of a non-qualified stock option to purchase shares of CorVel Corp (NASDAQ: CRVL) common stock, with a transaction date of August 6, 2026.